Literature DB >> 9012762

Pathogenesis of vasculitis syndromes.

M C Sneller1, A S Fauci.   

Abstract

The pathogenesis of vasculitis is complex and involves a variety of mechanisms acting in concert to bring about necrotizing inflammation of blood vessel walls. In recent years, there has been considerable progress in dissecting the immunologic abnormalities present in specific vasculitis syndromes. The primary immunopathogenic events that initiate the process of vascular inflammation and blood vessel damage, however, are still largely unknown. Although the cause of most vasculitis syndromes remains a mystery, advances in molecular and cellular immunology have defined many of the effector mechanisms that mediate inflammatory vascular damage. In this regard, modulation of the inflammatory response by specific cytokine and adhesion molecule antagonists is now possible and may prove beneficial in the treatment of vasculitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9012762     DOI: 10.1016/s0025-7125(05)70512-5

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  11 in total

Review 1.  Clinical utility of testing for antineutrophil cytoplasmic antibodies.

Authors:  D Vassilopoulos; G S Hoffman
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 2.  Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations.

Authors:  Laura B Hughes; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

3.  Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura.

Authors:  Y H Yang; M T Huang; S C Lin; Y T Lin; M J Tsai; B L Chiang
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

4.  Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis.

Authors:  R Karasawa; M S Kurokawa; K Yudoh; K Masuko; S Ozaki; T Kato
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

5.  Cigarette smoking and risk of primary systemic vasculitis: a propensity score matching analysis.

Authors:  Alireza Khabbazi; Babak Alinejati; Mehrzad Hajialilo; Morteza Ghojazadeh; Aida Malek Mahdavi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

Review 6.  Vasculitis associated with connective tissue disorders.

Authors:  Mittie K Doyle
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

7.  Cutaneous leukocytoclastic vasculitis associated with mycobacterial and salmonella infection.

Authors:  Sulaiman M Al-Mayouf; Sultan Bahabri; Mahmuod Majeed
Journal:  Clin Rheumatol       Date:  2006-10-05       Impact factor: 2.980

Review 8.  Immunopathogenesis of vasculitis.

Authors:  Raquel Cuchacovich
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

9.  No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis.

Authors:  M McKibbin; B Clark; H Lee; J D Isaacs; H C Gooi; A J Morrell
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

10.  Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.

Authors:  Alzírton de Lira Freire; Manoel Barros Bertolo; Antônio José de Pinho; Adil Muhib Samara; Sandra Regina Muchinechi Fernandes
Journal:  Clin Rheumatol       Date:  2004-04-02       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.